Researchers continue to excited about the medication , a groundbreaking dual agonist showing remarkable results in clinical trials for size reduction . It acts by targeting several hormones : GLP-1 and GIP, these, when activated , assist influence appetite and boost calorie burn. Preliminary findings indicate substantial weight loss and possible ad